相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA) Extended Follow-Up of a 2x2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol
Siri Lagethon Heck et al.
CIRCULATION (2021)
Using High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia in Symptomatic Patients A Cohort Study
Joan Walter et al.
ANNALS OF INTERNAL MEDICINE (2020)
Failure of Traditional Risk Factors to Adequately Predict Cardiovascular Events in Older Populations
Jarrod E. Dalton et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2020)
An overview of GLP-1 agonists and recent cardiovascular outcomes trials
Kelsey H. Sheahan et al.
POSTGRADUATE MEDICAL JOURNAL (2020)
Growth Differentiation Factor-8 (GDF8)/Myostatin Is a Predictor of Troponin I Peak and a Marker of Clinical Severity after Acute Myocardial Infarction
Alexandre Meloux et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Initial Invasive or Conservative Strategy for Stable Coronary Disease
David J. Maron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Mechanisms of Sodium-Glucose Cotransporter 2 Inhibition: Insights From Large-Scale Proteomics
Ele Ferrannini et al.
DIABETES CARE (2020)
Impact of Kidney Function on the Blood Proteome and on Protein Cardiovascular Risk Biomarkers in Patients With Stable Coronary Heart Disease
Joseph Yang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
The Evolving Understanding and Approach to Residual Cardiovascular Risk Management
Devinder S. Dhindsa et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Proteomics for personalized cardiovascular risk assessment: in pursuit of the Holy Grail
Peter Ganz et al.
EUROPEAN HEART JOURNAL (2020)
Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases
Jie Zheng et al.
NATURE GENETICS (2020)
Evinacumab in Patients with Refractory Hypercholesterolemia
Robert S. Rosenson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cardiotoxicity of Anthracyclines
Daniela Cardinale et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Utility of temporal profiles of new cardio-renal and pulmonary candidate biomarkers in chronic heart failure
Milos Brankovic et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial
Michael E. J. Lean et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
10-Year Risk Equations for Incident Heart Failure in the General Population
Sadiya S. Khan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: a systematic review and meta-analysis
Johanna A. Damen et al.
BMC MEDICINE (2019)
Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases
Helen Strongman et al.
LANCET (2019)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Genetic Polymorphisms in Sepsis and Cardiovascular Disease Do Similar Risk Genes Suggest Similar Drug Targets?
Taka-aki Nakada et al.
CHEST (2019)
Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology
Donald M. Lloyd-Jones et al.
CIRCULATION (2019)
Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA- REG OUTCOME Trial
David Fitchett et al.
CIRCULATION (2019)
Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies
Lisa Pennells et al.
EUROPEAN HEART JOURNAL (2019)
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Plasma protein patterns as comprehensive indicators of health
Stephen A. Williams et al.
NATURE MEDICINE (2019)
Undulating changes in human plasma proteome profiles across the lifespan
Benoit Lehallier et al.
NATURE MEDICINE (2019)
Reproducibility and Variability of Protein Analytes Measured Using a Multiplexed Modified Aptamer Assay
Adrienne Tin et al.
JOURNAL OF APPLIED LABORATORY MEDICINE (2019)
Circulating proteins as predictors of incident heart failure in the elderly
Markus Stenemo et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Carbohydrate antigen 125: a promising tool for risk stratification in heart diseases
Felipe Falcao et al.
BIOMARKERS IN MEDICINE (2018)
Prospective Countywide Surveillance and Autopsy Characterization of Sudden Cardiac Death POST SCD Study
Zian H. Tseng et al.
CIRCULATION (2018)
Cardiovascular Disease and Breast Cancer: Where These Entities Intersect A Scientific Statement From the American Heart Association
Laxmi S. Mehta et al.
CIRCULATION (2018)
Comparing biomarker profiles of patients with heart failure: atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction
Bernadet T. Santema et al.
EUROPEAN HEART JOURNAL (2018)
Neural cell adhesion molecule-1 may be a new biomarker of coronary artery disease
Peng Yu et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes A Systematic Review and Meta-analysis
Sean L. Zheng et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
SIRT2 deacetylase represses NFAT transcription factor to maintain cardiac homeostasis
Mohsen Sarikhani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Short-Term Global Cardiovascular Disease Risk Prediction in Older Adults
Anum Saeed et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
Michael E. J. Lean et al.
LANCET (2018)
Stability and reproducibility of proteomic profiles measured with an aptamer-based platform
Claire H. Kim et al.
SCIENTIFIC REPORTS (2018)
Improving Assessment of Drug Safety Through Proteomics Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of Torcetrapib
Stephen A. Williams et al.
CIRCULATION (2018)
Direct Comparison of Cardiac Troponin T and I Using a Uniform and a Sex-Specific Approach in the Detection of Functionally Relevant Coronary Artery Disease
Deborah Mueller et al.
CLINICAL CHEMISTRY (2018)
Genomic atlas of the human plasma proteome
Benjamin B. Sun et al.
NATURE (2018)
Co-regulatory networks of human serum proteins link genetics to disease
Valur Emilsson et al.
SCIENCE (2018)
TREM-1; Is It a Pivotal Target for Cardiovascular Diseases?
Kouassi T. Kouassi et al.
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2018)
A comprehensive map of molecular drug targets
Rita Santos et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
TGF-β1 affects cell-cell adhesion in the heart in an NCAM1-dependent mechanism
Maegen A. Ackermann et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
J. W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cancer Antigen 125 is Associated with Length of Stay in Patients with Acute Heart Failure
Hakki Kaya et al.
TEXAS HEART INSTITUTE JOURNAL (2017)
Cancer Antigen 125 is Associated with Length of Stay in Patients with Acute Heart Failure
Hakki Kaya et al.
TEXAS HEART INSTITUTE JOURNAL (2017)
Short term variation in NTproBNP after lifestyle intervention in severe obesity
Debora Fedele et al.
PLOS ONE (2017)
Cartilage intermediate layer protein 1 (CILP1): A novel mediator of cardiac extracellular matrix remodelling
Frans A. van Nieuwenhoven et al.
SCIENTIFIC REPORTS (2017)
SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy
Xiaoqiang Tang et al.
CIRCULATION (2017)
Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial
Rury R. Holman et al.
AMERICAN HEART JOURNAL (2016)
Von Willebrand Factor, ADAMTS13, and the Risk of Mortality The Rotterdam Study
Michelle A. H. Sonneveld et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 x 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
Geeta Gulati et al.
EUROPEAN HEART JOURNAL (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Using Aptamer-Based Technology to Probe the Plasma Proteome for Cardiovascular Disease Prediction
Marc S. Sabatine
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease
Peter Ganz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease
Nathan O. Stitziel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial
Edward W. Gregg et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes
Isabel Goncalves et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Low ADAMTS13 activity is associated with an increased risk of ischemic stroke
M. A. H. Sonneveld et al.
BLOOD (2015)
TREM-1 Mediates Inflammatory Injury and Cardiac Remodeling Following Myocardial Infarction
Amir Boufenzer et al.
CIRCULATION RESEARCH (2015)
Association of growth differentiation factor 11/8, putative anti-ageing factor, with cardiovascular outcomes and overall mortality in humans: analysis of the Heart and Soul and HUNT3 cohorts
Kristoff A. Olson et al.
EUROPEAN HEART JOURNAL (2015)
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
Marc P. Bonaca et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
David C. Goff et al.
CIRCULATION (2014)
Myostatin Regulates Energy Homeostasis in the Heart and Prevents Heart Failure
Nadine Biesemann et al.
CIRCULATION RESEARCH (2014)
Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents
John C. Rohloff et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
Francesco S. Loffredo et al.
CELL (2013)
Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score
Stig Lyngbaek et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Cohort Profile: The HUNT Study, Norway
S. Krokstad et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2013)
2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Clyde W. Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Protein-tyrosine phosphatases: a new frontier in platelet signal transduction
Y. A. Senis
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Beyond malignancy: the role of carbohydrate antigen 125 in heart failure
Chung-Lieh Hung et al.
BIOMARKER RESEARCH (2013)
Evaluation of Multiple Biomarkers of Cardiovascular Stress for Risk Prediction and Guiding Medical Therapy in Patients With Stable Coronary Disease
Marc S. Sabatine et al.
CIRCULATION (2012)
NT-proANP circulating level is a prognostic marker in stable ischemic heart disease
Emanuele Barbato et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
Life's Simple Measures: Unlocking the Proteome
Edward Brody et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Trend of Westernization of Etiology and Clinical Characteristics of Heart Failure Patients in Japan - First Report From the CHART-2 Study
Nobuyuki Shiba et al.
CIRCULATION JOURNAL (2011)
Roles of atrial natriuretic peptide and its therapeutic use
Yoshihiko Saito
JOURNAL OF CARDIOLOGY (2010)
Heparan sulfate Ndst1 regulates vascular smooth muscle cell proliferation, vessel size and vascular remodeling
Neeta Adhikari et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Larry Gold et al.
PLOS ONE (2010)
Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling
Ross L. Prentice et al.
GENOME MEDICINE (2010)
Cardiovascular risk in rheumatoid arthritis
Michael T. Nurmohamed
AUTOIMMUNITY REVIEWS (2009)
The Value, Qualification, and Regulatory Use of Surrogate End Points in Drug Development
C. D. Lathia et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology
Persoulla Nicolaou et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
General cardiovascular risk profile for use in primary care - The Framingham Heart Study
Ralph B. D'Agostino et al.
CIRCULATION (2008)
Rheumatoid Arthritis and Cardiovascular Disease
Saurabh S. Dhawan et al.
CURRENT ATHEROSCLEROSIS REPORTS (2008)
A human polymorphism of protein phosphatase-1 inhibitor-1 is associated with attenuated contractile response of cardiomyocytes to β-adrenergic stimulation
Guoli Chen et al.
FASEB JOURNAL (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of torcetrapib in patients at high risk for coronary events
Philip J. Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes
Ruth L. Coleman et al.
DIABETES CARE (2007)
Optimal medical therapy with or without PCI for stable coronary disease
William E. Boden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Use and misuse of the receiver operating characteristic curve in risk prediction
Nancy R. Cook
CIRCULATION (2007)
Association of atrial natriuretic peptide and type A natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension
Speranza Rubattu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Plasma natriuretic peptide levels and the risk of cardiovascular events and death
TJ Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction - A long-term follow-up analysis
S Suzuki et al.
CIRCULATION (2004)
A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development
T Takahashi et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Primary and subsequent coronary risk appraisal: New results from The Framingham Study
RB D'Agostino et al.
AMERICAN HEART JOURNAL (2000)
分享论文
